In response to DNA damage, SKP2 enhances phosphorylation and ubiquitination of programmed cell death protein 4 (PDCD4) to inhibit apoptosis with subsequent increase in cell growth and proliferation of breast cancer cells 34. Here, SKP2 is linked to breast carcinoma.